Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Director/PDMR Shareholding

3 May 2013 07:00

RNS Number : 9289D
Plant Health Care PLC
03 May 2013
 



Plant Health Care plc

Thursday, 03 May 2013

 

PLANT HEALTH CARE plc (THE "COMPANY")

 

Director/ PDMR Shareholding

 

On 01 May 2013, the Company approved the allotment of 23,727 ordinary shares of 1p ("Ordinary Shares") to the following current and former non-executive directors, in accordance with the Company's existing contractual arrangements, which comprise part of the non-executive directors' remuneration packages and are payable in lieu of a part of their fees. The shares were allotted at 89p per share, calculated at the closing middle market price derived from the Daily Official List on 25 April 2013.

 

Non-executive director

Value of remuneration used to purchase shares

Number of Ordinary Shares allotted

David Buckeridge(1)

£10,500.00

11,798

Former director(2)

£10,616.67

11,929

TOTAL:

23,727

(1) Allotted in the name of David Buckeridge Investigations Ltd., a personal service company(2) Allotted in the name of You and Your Health Ltd., a personal service company

 

Application has been made for 23,727 Ordinary Shares (the 'New Shares') to be admitted to trading on AIM and admission is expected to occur on 09 May 2013. The New Shares will rank pari passu with the Company's existing Ordinary Shares.

 

 

 

2. DIRECTOR'S HOLDINGS

 

Following the above-mentioned allotment of Ordinary Shares, the beneficial interest of the director concerned in the enlarged Ordinary Share capital of the Company is as shown below:

 

Name

Ordinary Share holding

Percentage of enlarged Ordinary Share capital

Share Options

LTIPs

David Buckeridge

166,553

0.24%

N/A

N/A

 

Following admission of the New Shares, the total issued share capital of the Company will be 70,529,298 Ordinary Shares, all of which have voting rights. There are no shares in treasury.

 

The above figure (70,529,298) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Plant Health Care plc under the FSA's Disclosure and Transparency Rules.

-: Ends :-

 

Enquiries:

Andrew C. Wood FCIS

Company Secretary

020 8866 5702

 

Nomura Code Securities

Clare Terlouw / Chris Golden

Tel: +44 (0)20 7776 1200

www.nomuracode.com

Powerscourt

Paul Durman / Nick Dibden/ Sophie Moate

Tel: +44 20 7250 1446

paul.durman@powerscourt-group.com

nick.dibden@powerscourt-group.com

sophie.moate@powerscourt-group.com

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSSUFWEFDSEFI
Date   Source Headline
2nd Jul 20242:23 pmRNSForm 8.3 - Plant Health Care plc
1st Jul 20249:46 amRNSForm 8.5 (EPT/NON-RI)
1st Jul 20247:32 amRNSForm 8.3 - Plant Health Care plc
28th Jun 20241:38 pmRNSForm 8.3 - Plant Health Care PLC
28th Jun 202411:35 amRNSForm 8.3 - Plant Health Care plc
28th Jun 202411:31 amRNSResult of GM & AGM
28th Jun 202410:13 amRNSForm 8.3 - Plant Health Care Plc
28th Jun 20249:16 amRNSForm 8.5 (EPT/NON-RI)
28th Jun 20248:59 amRNSForm 8.3 - Plant Health Care plc
27th Jun 20241:03 pmPRNForm 8.3 - Plant Health Care Plc
27th Jun 202412:13 pmRNSForm 8.3 - Plant Health Care plc
27th Jun 20249:43 amRNSForm 8.3 - Plant Health Care plc
27th Jun 20249:08 amRNSForm 8.5 (EPT/NON-RI)
26th Jun 20245:55 pmRNSForm 8.3 - Plant Health Care
26th Jun 20241:23 pmRNSRecommended Cash Acquisition of Plant Health Care
12th Jun 20245:22 pmRNSNotice of General Meeting
5th Jun 20245:09 pmRNSNotice of Annual General Meeting
4th Jun 20247:00 amRNSExpanded New California Label for Employ®
31st May 20245:05 pmRNSFull Year Results
16th May 20242:24 pmRNSHolding(s) in Company
14th May 20242:58 pmRNSHolding(s) in Company
8th May 20247:00 amRNSTrading Update
22nd Apr 20247:00 amRNSApproval of Harpinαβ in Belgium
16th Apr 20247:00 amRNSPlant Health Care--China Distribution with AMVAC
4th Apr 20247:00 amRNSApproval of PHC68949 in Mexico
4th Mar 20241:55 pmRNSHolding(s) in Company
24th Jan 20244:27 pmRNSHolding(s) in Company
2nd Jan 20247:00 amRNSBrazil approves TEIKKOâ„¢
20th Dec 20237:00 amRNSBoard Changes and Grant of Options
19th Dec 20233:34 pmRNSHolding(s) in Company
30th Nov 20231:45 pmRNSHolding(s) in Company
28th Nov 20233:16 pmRNSHolding(s) in Company
27th Nov 20234:03 pmRNSHolding(s) in Company
27th Nov 20231:27 pmRNSHolding(s) in Company
24th Nov 20234:19 pmRNSDirector/PDMR Shareholding
24th Nov 202310:57 amRNSDirector/PDMR Shareholding
23rd Nov 20232:31 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSTrading Update
31st Oct 20237:00 amRNSChange of Adviser
20th Oct 20237:00 amRNSHolding(s) in Company
3rd Oct 20236:28 pmRNSPlant Health Care PREtec Product with Agrii UK
28th Sep 20237:00 amRNSNew PREtec Products Announced
27th Sep 20237:00 amRNSUnaudited Interim Results
25th Sep 20237:00 amRNSPREtec Products Submitted for Regulatory Approval
31st Aug 20237:00 amRNSNotice of Results & Investor Presentation
18th Aug 20237:00 amRNSNew Product Regulatory Approval In Brazil
1st Aug 20237:00 amRNSApproval for Sale of Harpin aß Granted in Poland
24th Jul 20237:00 amRNSGrant of Options
12th Jul 202312:27 pmRNSHolding(s) in Company
30th Jun 20235:07 pmRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.